AI in Clinical Trials Doesn’t Have a Capability Problem. It Has a Honesty Problem.
Six AI models picked the same "random" number. Clinical ops leaders are finally asking what that reveals about every...
AI Drug Discovery
AI Is Clearing Phase I. That’s the Wrong Finish Line.
Of 117 AI-enabled drug assets tracked in clinical trials, only 8 have cleared Phase II. Speed is real. Efficacy...
AI Drug Discovery Has $8.9 Billion in Hype and Zero FDA Approvals: When Does the Bill Come Due?
AI drug discovery raised $8.9B in 2024, yet no AI-discovered drug holds FDA approval. The gap between algorithmic promise...
AI-Designed Drugs Are Reaching Human Trials. Now Comes the Hard Part.
Healx's HLX-4310 Phase 1/2 trial in osteosarcoma shows AI drug discovery maturing—but adaptive dose-escalation in adolescent oncology exposes trial...
$7 Billion Into AI Drug Discovery and Zero Approved Drugs: The Industry Is Funding the Wrong Race
$7B committed to AI drug discovery, zero approved drugs. The real bottleneck is clinical development—and the capital hasn't caught...